Signaling pathways in cell death and survival after photodynamic therapy

Journal of Photochemistry and Photobiology B: Biology

Volumn 57, Issue 1, 2000, Pages 1-13

  Moor, Anne C E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Apoptosis; Necrosis; Photodynamic therapy; Rescue response; Signaling pathways

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; CALCIMYCIN; CALCIUM; CALPHOSTIN C; CASPASE 3; CASPASE 8; CASPASE 9; CERAMIDE; CYSTEINE; CYSTEINE PROTEINASE; CYTOCHROME C; DEOXYADENOSINE TRIPHOSPHATE; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; FAS ANTIGEN; GLUCOSE REGULATED PROTEIN; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE A2; PHOTOSENSITIZING AGENT; PHTHALOCYANINE; PROTEIN BCL 2; PROTEIN C FOS; PROTEIN KINASE C; ROSE BENGAL; SINGLET OXYGEN; STRESS ACTIVATED PROTEIN KINASE; UNINDEXED DRUG;

ANIMAL CELL; APOPTOSIS; CELL CLONE; CELL DEATH; CELL MEMBRANE; CELL STRAIN HL 60; CELL STRAIN U937; CELL SURVIVAL; CELLULAR DISTRIBUTION; CHO CELL; CLONOGENESIS; DNA DAMAGE; DOWN REGULATION; DRUG EFFECT; HUMAN; HUMAN CELL; LEUKEMIA L 5178 Y; LEUKEMIA P 388; MEMBRANE DAMAGE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SECOND MESSENGER; TARGET CELL DESTRUCTION; TREATMENT OUTCOME;

EID: 0033794124     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(00)00065-8     Document Type: Review

References (116)

1. Photodynamic therapy
2. Photodynamic therapy of cancer
3. New applications in photodynamic therapy
4. The photodecontamination of cellular blood components: Mechanisms and use of photosensitization in transfusion medicine
5. Photodynamic therapy of arteries. A novel approach for treatment of experimental intimal hyperplasia
6. Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy
7. The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumours
8. Photosensitizer delivery mediated by macromolecular carrier systems
9. Molecular, cellular, and tissue responses following photodynamic therapy
10. Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells
11. The photobiology of photodynamic therapy: Cellular targets and mechanisms
12. BPD-MA-mediated photosensitization in vitro and in vivo: Cellular adhesion and beta1 integrin expression in ovarian cancer cells
13. Photodynamic therapy inhibits cell adhesion without altering integrin expression
14. Decreased expression of HLA class I on ocular melanoma cells following in vitro photodynamic therapy
15. Photodynamic alteration of the surface receptor expression pattern of murine splenic dendritic cells
16. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo
17. Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-kappa B DNA binding
18. Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages
19. Apoptosis occurs in lymphoma cells but not in hepatoma cells following ionizing radiation and photodynamic therapy
20. Photodynamic therapy with photofrin II induces programmed cell death in carcinoma cell lines
21. Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX
22. Initiation of apoptosis versus necrosis by photodynamic therapy with chloroaluminum phthalocyanine
23. Silicon phthalocyanine Pc 4 and red light causes apoptosis in HIV-infected cells
24. Modification of the photodynamic action of delta-aminolaevulinic acid (ALA) on rat pancreatoma cells by mitochondrial benzodiazepine receptor ligands
25. Photodynamic tumor therapy: Mitochondrial benzodiazepine receptors as a therapeutic target
26. Mitochondrial photodamage and PDT-induced apoptosis
27. The mode of cell death induced by photodynamic treatment depends on cell density
28. The role of subcellular localization in initiation of apoptosis by photodynamic therapy
29. Rapid cytochrome c release, activation of caspases 3, 6, 7 and 8 followed by Bap31 cleavage in HeLa cells treated with photodynamic therapy
30. Photodynamic therapy-induced apoptosis in lymphoma cells: Translocation of cytochrome c causes inhibition of respiration as well as caspase activation
31. Photodynamic therapy: A mitochondrial inducer of apoptosis
32. Mitochondria and apoptosis
33. Singlet oxygen produced by photodynamic action causes inactivation of the mitochondrial permeability transition pore
34. Caspases: Enemies within
35. Caspases: The proteases of the apoptotic pathway
36. Emerging roles of caspase-3 in apoptosis
37. Rapid tyrosine phosphorylation of HS1 in the response of mouse lymphoma L5178Y-R cells to photodynamic treatment sensitized by the phthalocyanine Pc 4
38. Ceramide generation in response to photodynamic treatment of L5178Y mouse lymphoma cells
39. Death receptors: Signaling and modulation
40. Release of cytochrome c, Bax migration, Bid cleavage, and activation of caspases 2, 3, 6, 7, 8, and 9 during endothelial cell apoptosis
41. Caspase-8 mediates caspase-3 activation and cytochrome c release during singlet oxygen-induced apoptosis of HL-60 cells
42. Protease activation and cleavage of poly(ADP-ribose) polymerase: An integral part of apoptosis in response to photodynamic treatment
43. Photodynamic therapy induces caspase-3 activation in HL-60 cells
44. Death by a thousand cuts: An ever increasing list of caspase substrates
45. Activation of the apoptotic endonuclease DFF40 (caspase-activated DNase or nuclease). Oligomerization and direct interaction with histone H1
46. Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes
47. BCL-2 family members and the mitochondria in apoptosis
48. The induction of partial resistance to photodynamic therapy by the protooncogene BCL-2
49. Antisense bcl-2 retrovirus vector increases the sensitivity of a human gastric adenocarcinoma cell line to photodynamic therapy
50. Bcl-2 overexpression blocks caspase activation and downstream apoptotic events instigated by photodynamic therapy
51. Apoptosis overview emphasizing the role of oxidative stress. DNA damage and signal-transduction pathways
52. Cytoplasmic free calcium changes as a trigger mechanism in the response of cells to photosensitization
53. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
54. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
55. Early release of mitochondrial cytochrome c and expression of mitochondrial epitope 7A6 with a porphyrin-derived photosensitizer: Bcl-2 and Bcl-xL overexpression do not prevent early mitochondrial events but activity
56. Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection
57. The Bcl-2 protein family: Arbiters of cell survival
58. Overexpression of Bcl-X(L) prevents caspase-3-mediated activation of DNA fragmentation factor (DFF) produced by treatment with the photochemotherapeutic agent BPD-MA
59. A role for the transient increase of cytoplasmic free calcium in cell rescue after photodynamic treatment
60. Ca(2+)-mediated prostaglandin E2 induction reduces haematoporphyrin-derivative-induced cytotoxicity of T24 human bladder transitional carcinoma cells in vitro
61. HPD-induced photodynamic changes in intracellular cyclic AMP levels in human bladder transitional carcinoma cells, clone T24
62. Release of prostaglandin E2 from cells by photodynamic treatment in vitro
63. Photodynamic therapy mediated induction of early response genes
64. Role of Rac GTPase in the nuclear signaling by EGF
65. Strong and prolonged induction of c-jun and c-fos proto-oncogenes by photodynamic therapy
66. The role of protein kinase C activity in the killing of Chinese hamster ovary cells by ionizing radiation and photodynamic treatment
67. Activation of protein kinase C is required for protection of cells against apoptosis induced by singlet oxygen
68. The phosphatase inhibitor calyculin antagonizes the rapid initiation of apoptosis by photodynamic therapy
69. Ceramide in apoptosis: Does it really matter?
70. 2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene
71. The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene
72. The role of ceramide in cell signaling
73. Association of ceramide accumulation with photodynamic treatment-induced cell death
74. Niemann-Pick human lymphoblasts are resistant to phthalocyanine 4-photodynamic therapy-induced apoptosis
75. Stress signals for apoptosis: Ceramide and c-Jun kinase
76. Lysosomes and microtubules as targets for photochemotherapy of cancer
77. Different apoptotic pathways are induced from various intracellular sites by tetraphenylporphyrins and light
78. Inhibition of epidermal growth factor receptor tyrosine kinase activity by hypericin
79. Photosensitized inhibition of growth factor-regulated protein kinases by hypericin
80. Involvement of epidermal growth factor receptor (EGF-R)-tyrosine kinase pathway in photodynamic therapy-mediated cell death
81. The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin
82. Stimulation of stress-activated protein kinase and p38 HOG1 kinase in murine keratinocytes following photodynamic therapy with benzoporphyrin derivative
83. Activation of JNK and p38 but not ERK MAP kinases in human skin cells by 5-aminolevulinate-photodynamic therapy
84. Mitogen-activated protein kinase (p38-, JNK-, ERK-) activation pattern induced by extracellular and intracellular singlet oxygen and UVA
85. Promotion of photodynamic therapy-induced apoptosis by stress kinases
86. Toxic and signaling effects of photochemically or chemically generated singlet oxygen in biological systems
87. Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis
88. The role of the stress-activated protein kinase (SAPK/JNK) signaling pathway in radiation-induced apoptosis
89. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control
90. Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB
91. NF-kappa B transcription factor and human immunodeficiency virus type 1 (HIV-1) activation by methylene blue photosensitization
92. Nuclear factor kappa B binding activity in mouse L1210 cells following photofrin II-mediated photosensitization
93. Nf-kappa B: An important transcription factor in photobiology
94. Pyropheophorbide-a methyl ester-mediated photosensitization activates transcription factor NF-kappaB through the interleukin-1 receptor-dependent signaling pathway
95. Role of NF-κB in colon cancer cell apoptosis mediated by aminopyropheorbide photosensitization
96. Nuclear factor-kappaB activation by the photochemotherapeutic agent verteporfin
97. Photodynamic therapy results in induction of WAF1/CIP1/P21 leading to cell cycle arrest and apoptosis
98. Involvement of nitric oxide during phthalocyanine (Pc4) photodynamic therapy-mediated apoptosis
99. Induction of the cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/Waf1) by nitric oxide-generating vasodilator in vascular smooth muscle cells
100. Induction of p53 and p21/WAF1/ CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells
101. Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431
102. Photodynamic therapy sensitivity is not altered in human tumor cells after abrogation of p53 function
103. Etk/Bmx, a PH-domain containing tyrosine kinase, protects prostate cancer cells from apoptosis induced by photodynamic therapy or thapsigargin
104. Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3'-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells
105. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents
106. Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins
107. Stress protein expression in murine tumor cells following photodynamic therapy with benzoporphyrin derivative
108. Elevation of GRP-78 and loss of HSP-70 following photodynamic treatment of V79 cells: Sensitization by nigericin
109. 2+ disturbances, and cell death in renal epithelial cells
110. Glucose regulated protein induction and cellular resistance to oxidative stress mediated by porphyrin photosensitization
111. GRP78 induction by calcium ionophore potentiates photodynamic therapy using the mitochondrial targeting dye victoria blue BO
112. Increased transcription and translation of heme oxygenase in Chinese hamster fibroblasts following photodynamic stress or Photofrin II incubation
113. Dark induction of haem oxygenase messenger RNA by haematoporphyrin derivative and zinc phthalocyanine; agents for photodynamic therapy
114. Heat shock protein 70 kDa: Molecular biology, biochemistry, and physiology